BRAIN Biotech AG financial highlights

in € million 2021/22 2020/21 2019/20
Consolidated income statement data:
Revenue 49.5 38.4 38.2
Total operating performance 53.1 40.7 39.2
EBITDA –1.3 –2.5 –3.9
Adjusted EBITDA –0.1 –2.1 –2.0
Net loss for the reporting period –6.3 –4.7 –9.0
Consolidated balance sheet data:
Total equity 34.2 41.8 26.1
Equity ratio (in %) 43.9% 53.8% 36.2%
Total assets 78 77.7 72.2
Consolidated cash flow data:
Cash flows from operating activities –1.5 –3.9 –4.8
Cash flows from investing activities –12.7 –2.2 –4.5
Cash flows from financing activities –2.0 11.6 –13.1

Share this page